Should I refer a patient with a congenital melanocytic nevus (CMN) to a dermatologist (derm) as a general practitioner (GP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Referral Guidelines for Congenital Melanocytic Nevi

Yes, you should refer patients with large, giant, or multiple congenital melanocytic nevi (CMN) of any size to a dermatologist, while solitary small and medium CMN without concerning features can be managed by primary care providers. 1

Referral Decision Algorithm Based on CMN Characteristics

Immediate Dermatology Referral Required:

  • Large CMN (>20 cm projected adult size)
  • Giant CMN (>40 cm projected adult size)
  • Multiple CMN of any size
  • Any CMN with concerning features:
    • Color variation
    • Nodules
    • Symptoms (pain, bleeding, itching)
    • Rapid growth
    • Ulceration
    • Location in cosmetically sensitive areas

Referral Can Be Delayed or Managed by GP:

  • Solitary small CMN (<1.5 cm)
  • Solitary medium CMN (1.5-20 cm)
  • No concerning features present

Risk Assessment

The risk of melanoma development varies significantly based on CMN characteristics:

  • Giant CMN (>40 cm): Highest risk (1-3.6%)
  • Multiple CMN with a giant CMN >60 cm: 8% risk of melanoma 1
  • Small to medium solitary CMN: Lower risk (0.7-1.7%)

Melanoma risk is significantly higher in patients with:

  • Projected adult size >40 cm
  • Numerous "satellite" nevi
  • Trunk location
  • Multiple medium-sized CMN 1

Monitoring Recommendations

For High-Risk CMN (Large, Giant, Multiple):

  • Initial evaluation by dermatologist in neonatal period
  • Follow closely during infancy with visits every 3 months
  • Yearly dermatologist evaluation minimum after first year
  • Regular palpation of CMN and regional lymph nodes
  • MRI screening for patients with multiple medium CMN, ≥10 "satellite" lesions, or giant CMN to evaluate for neurocutaneous melanosis (NCM)

For Lower-Risk CMN (Small, Medium, Solitary):

  • Can be monitored by GP
  • Regular visual inspection and palpation
  • Patient/caregiver education on concerning changes
  • No routine MRI screening needed unless neurological symptoms develop 1

Important Clinical Pearls

  1. Palpation is crucial: Melanoma in CMN can present as deep nodules without overlying color change 1

  2. Monitor for these changes that require prompt dermatology evaluation:

    • Rapid growth
    • Bleeding
    • Pain
    • Development of a lump or nodule
    • Ulceration 1
  3. Proliferative nodules can develop within CMN and may mimic melanoma clinically and histologically, but are typically benign 2

  4. Pregnancy can affect CMN: Increased estrogen levels during pregnancy may cause CMN to increase in size and potentially increase risk of malignant transformation 3

  5. Avoid shave biopsies of suspicious pigmented lesions as they may underestimate depth and lead to inappropriate management 4

Patient Education

Instruct patients/caregivers to:

  • Monitor nevi visually and with palpation
  • Report concerning changes promptly
  • Follow sun protection guidelines (sunscreen, protective clothing, seeking shade)
  • Understand that some changes in CMN are normal (color variation, texture changes) 1

By following these guidelines, GPs can appropriately triage patients with CMN, ensuring those at higher risk receive timely specialist evaluation while avoiding unnecessary referrals for lower-risk lesions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach for Eyebrow Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.